Trial intelligence / Profile preview

Mannitol and Hemofiltration Effects on Monocytes After CABG

NCT00426192Phase 4Unknown

Sponsor
Saarland University Medical Center
Start
Oct 2003
Modality
Inhalation Devices, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Bronchitol in Systemic Inflammatory Response Syndrome (SIRS), sponsored by Saarland University Medical Center. Status: unknown.

02

Drugs

Bronchitol
03

Conditions

Systemic Inflammatory Response Syndrome (SIRS)

Beyond the preview

Go deeper on NCT00426192.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00426192.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call